The SENSIMED Triggerfish is a revolutionary solution for continuous monitoring of intra-ocular pressure (IOP) in glaucoma patients.
Sensimed develops, manufactures and sells Triggerfish®, a breakthrough, non-invasive solution for continuous monitoring of fluctuations in intraocular pressure (IOP) to aid the diagnosis and treatment of glaucoma. The customers are opthalmologists. The worldwide market is $3BN-5BN and Sensimed has no competition. The had sales of $1M in 2011 and is well underway to achieve $2.8M in 2012.